News
-
Ministry of Health. Medical devices, indications relating to the application of the European regulation 2017/745
La Direzione Generale dei dispositivi medici e del servizio farmaceutico del Ministero della salute chiarisce, con la Circolare del 12…
Leggi » -
FNOMCeO update. Doctors suspended, one in four got vaccinated. 1,767 doctors and dentists are left out
One in four, among the doctors and dentists suspended pursuant to Legislative Decree 44, has been vaccinated, and is…
Leggi » -
ISTAT. Industry turnover: trend increases in September for all sectors except the pharmaceutical one
In September, industry turnover, net of seasonal factors, is estimated to increase by 0.1% compared to August. There…
Leggi » -
European day on the conscious use of antibiotics
Today 18 November is the "European Antibiotic Awareness Day" (EAAD) as part of the contextual World Awareness Week…
Leggi » -
Alarm of the Regions. Decrease of 2.2 billion euros compared to 2020 for healthcare in 2021 and critical issues for regional budgets
Healthcare resources in 2021 and critical issues for regional budgets: Regions meet the group leaders of the Senate and Chamber.…
Leggi » -
Nomisma Observatory. The system of generic drugs in Italy
Focus on equivalents: a horse cure is needed for pharmaceutical reshoring Egualia – 15 November 2021 In the annual study…
Leggi » -
How much does a company pay in employee gross salary that takes 1400 euros net in 2021? Calculation and examples
Between the net salary received by the worker and the amount actually paid by the company in terms of salary, the difference can be…
Leggi » -
AIISF Naples. Restored ISF access to the "Clinic Center" structure
After a period of inaccessibility at the "Clinic Center" facility in Naples, due to the Covid emergency, from 17 November next it will be…
Leggi » -
Parliament approved the law on rare diseases and orphan drugs. However, Aifa suspends access to the Fund for the reimbursement of orphan drugs
The Parliament has just unanimously approved the law on rare diseases with a strong reference to orphan drugs, both for…
Leggi » -
Johnson&Johnson si divide in due società quotate in Borsa
L’azienda farmaceutica ha annunciato l’intenzione di dividersi in due distinte realtà sul mercato delle quotazioni: una focalizzata sui prodotti al…
Leggi »